SCHEMBL12440966

SCHEMBL12440966

Cc1cccc(Br)c1OCc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAOB P27338 4/20 0.44
NPSR1 Q6W5P4 3/20 0.43
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
CCR5 P51681 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAOA P21397 1/20 0.41
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12772155 0.85 HTR1A (0.50) LMNAMAPTKMT2AMAOBGAA
SCHEMBL9893996 0.83 KMT2A (0.46) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL16800856 0.83 SCN8A (0.49) LMNAMAOBNPC1RAB9ASMN1; SMN2
SCHEMBL12514196 0.81 KMT2A (0.45) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL13429917 0.81 MAOB (0.44) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL13429681 0.80 KMT2A (0.46) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL12440960 0.79 THRA (0.51) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL12440955 0.77 MAOB (0.56) MAOBMAOASMN1; SMN2THRATHRB
SCHEMBL30679623 0.77 MAPT (0.43) LMNAMAPTKMT2AMEN1CYP1A2
SCHEMBL1154801 0.75 THRB (0.56) LMNAMAPTKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9318706-B2 Laminated structure, method for producing same, and electronic element comprising same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME EPCAM, ITGA1, ITGB1 LMNA 331/4885MAPT 456/4885KMT2A 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.